Clinical Trials Browser

Active not recruiting × Has results × polatuzumab vedotin × Clear all

NCT05171647 2026-05-07

SUNMO

Phase 3 Active not recruiting

208 enrolled 12 charts

Lymphoma, Non-Hodgkin

NCT04665765 2025-09-03

Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Phase 2 Active not recruiting

41 enrolled 12 charts

Lymphoma, Large B-Cell, Diffuse